GlassScriptPhysician profile
Kimberly Ann Steele
NPI 1083614747
$1,134.44
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $84.10 · 2021: $44.78 · 2022: $140 · 2023: $390 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $272.85 | 2022-2024 | Infuse, Miebo |
| Allergan, INC. | $181.98 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $121.87 | 2020-2024 | Acuvue |
| Genzyme Corporation | $104.22 | 2019 | |
| Sun Pharmaceutical Industries INC. | $85.61 | 2019-2023 | Cequa |
| Alcon Vision LLC | $76.78 | 2020-2023 | Precision 1 |
| Tearlab Corp | $46.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.34 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $34.84 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.45 | 2019 | |
| Dompe US, INC. | $32.73 | 2024 | Oxervate |
| Oyster Point Pharma, INC. | $20.96 | 2022 | |
| Mallinckrodt Enterprises LLC | $19.41 | 2019 | |
| Coopervision INC. | $17.23 | 2020 | |
| Aerie Pharmaceuticals, INC. | $14.79 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $14.04 | 2023 | |
| Optos, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.